Sebela Women's Health Inc.
Quick facts
Phase 3 pipeline
- LevoCept · Women's Health / Endocrinology
LevoCept is a selective estrogen receptor modulator (SERM) that modulates estrogen signaling to treat menopausal symptoms and related conditions in women. - VeraCept · Endocrinology
VeraCept is a medication that works by inhibiting the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2).
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Sebela Women's Health Inc.
What is Sebela Women's Health Inc.'s pipeline?
Sebela Women's Health Inc. has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include LevoCept, VeraCept.
Related
- Sector hub: All tracked pharma companies